Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine N-butylbromide for colonoscopic polyp detection
NL-OMON36608Active, not recruiting
- Sponsor
- Deventer Ziekenhuis
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of hyoscine butylbromide in colonic polyp (2 arms), sponsored by Deventer Ziekenhuis. Primary endpoint: Polyp detection ratio. Started Jan 2011; status: active, not recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
colonic polyp
Beyond the preview
Go deeper on NL-OMON36608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36608.